Our experience with pancreatic cancer and its relation to diabetes mellitus
Authors:
Tomáš Krechler 1; Miroslav Zeman 1; Marek Vecka 2; Marie Jáchymová 2; Josef Hořejš 3; Zdeněk Krška 4; Jan Ulrych 4; Jana Dušková 5; Aleš Žák 1
Authors place of work:
Univerzita Karlova v Praze, 1. lékařská fakulta, IV. interní klinika VFN
1; Univerzita Karlova v Praze, 1. lékařská fakulta, Ústav klinické biochemie a laboratorní diagnostiky
2; Univerzita Karlova v Praze, 1. lékařská fakulta, Radiodiagnostická klinika VFN
3; Univerzita Karlova v Praze, 1. lékařská fakulta, 1. chirurgická klinika VFN
4; Univerzita Karlova v Praze, 1. lékařská fakulta, Ústav patologie
5
Published in the journal:
Čas. Lék. čes. 2010; 149: 291-296
Category:
Original Article
Summary
Background.
Despite the introduction of new imaging methods, the prognosis of pancreatic carcinoma (PC) remains hopeless. Therefore, there has been exerted much effort to elucidate the risk factor enabling the diagnosis of PC in the „preclinical state“. At the time of PC diagnosis, more than 30 % of patients suffer from diabetes mellitus, much more often than in the rest of the population. It is not clear whether DM is a risk factor for PC onset or DM appears secondary to the destruction of the gland by the tumor progression or by the effect of unknown factors produced by the cancer cells.
Methods and Results.
We enrolled 204 individuals into the study, 69 of them were controls, 70 patients had type 2 diabetes mellitus and 65 cases had newly diagnosed PC. The patients with PC had in 68% of cases disturbed glucose homeostasis and significantly higher values of insulin resistance index (HOMA-IR) in comparison with the control group. The presence of glucose homeostasis disturbances does not influence tumor staging and localization.
Conclusions.
Results of our pilot study confirmed the so far unsatisfactory state of PC diagnostics (majority of cases fall to stages III and IV) and corroborated the close relation to DM. The early markers for the risk of pancreatic carcinoma development should be searched among the factors participating in the regulation of the glucose homeostasis and insulin sensitivity.
Key words:
pancreatic cancer, insulin resistance, diabetes mellitus.
Zdroje
1. Jemal A, Seigel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43–66.
2. Ferlay J, Autier P, Boniol M, et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581–592.
3. Novotvary 2006. Praha, ÚZIS a NOR, 2009.
4. Castillo FC, Jimenez RE. Pancreatic cancer, cystic pancreatic neoplasms, and other nonendocrine pancreatic tumors. In: Feldman M, Friedman LS, Sleisinger MH. Eds, Sleisinger & Fordtrans’s Gastrointestinal and Liver Dissease. Pathophysiology/Diagnosis/Management. 7th ed. Philadelphia; WB. Saunders Company: 2002, 970-987.
5. Tsuchia R, Noda T, Harada N, et al. Colective review of small carcinoma of the pancreas. Ann Surg 1986; 203: 77.
6. Niederhuber JE, Brennan MF, Menck HR. The national cancer data base report on pancreatic cancer. Cancer 1995; 76: 1671–1677.
7. DiMagno EP, Reber HA, Tempero MA. AGA technical rewiew on the epidemiology, diagnosis and treatment of pancreatic ductal adenocarcinoma Gastroenteroloy 1999; 177: 1464–1484.
8. Michaud DS, Giovannucci E, Willett WC, et al. Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA 2001; 286: 921–929.
9. Van den Brandt PA, Goldbohm RA. Nutrition in the prevention of gastrointestinal cancer. Best Pract Res Clin Gastroenterol 2006; 20: 589–603.
10. Anand P, Kunnumakkara AB, Sundaram C, et al. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res 2008; 25: 2097–2116.
11. Hermanová M, Nenutil R, Křen L, et al. Proliferative activity in pancreatic intraepithelial neoplasias of chronic pancreatitis resection specimen: Detection of high-risk lesions. Neoplasma 2004; 51: 400–404.
12. Maitra A, Hruban RH. Pancreatic cancer. Annu Rev Pathol 2008; 3: 157–188.
13. Hruban RH, Maitra A, Kern SE, Goggins M. Precursors to pancreatic cancer. Gastroenterol Clin North Am 2007; 36: 831–849.
14. Zavoral M, et al: Karcinom pankreatu. Praha: Galén 2005.
15. Koorstra JB, Hustinx SR, Offerhaus GJ, Maitra A. Pancreatic carcinogenesis. Pancreatology 2008; 8: 110–1125.
16. Bramhall SR, Allum WH, Jones AG, et al. Treatment and survival in 13560 patients with pancreatic cancer and incidence of the diseases in the West Midlands: an epidemiological study. Br J Surg 1995; 82: 111–115.
17. Conlon KC, Klimstra DS, Brennan MF. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg 1996; 223: 273–279.
18. Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000; 4: 567–579.
19. Ishikawa O, Ohigashi H, Imaoka S, et al. Minute carcinoma of the pancreas measuring 1 cm or less in diameter— collective review of Japanese case reports. Hepatogastroenterology 1999; 46: 8–15.
20. Rulyak SJ, Kimmey MB, Veenstra DL, Brentnall TA. Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds. Gastrointest Endosc. 2003; 57: 23–29.
21. Chari ST, Leibson CL, Rabe KG, et al. Probality of pancreatic cancer following diabetes: a population based study. Gastroenterology 2005; 129: 504–511.
22. Pannala R, Leirness JB, Bamlet WR, et al. Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology 2008; 134: 981–987.
23. Trna J, Dítě P, Hermanová M, et al. Diabetes mellitus in patients suffering from pancreatic cancer. Čes a slov gastroenter a hepatol 2008; 62: 69–73.
24. Chari ST. Detecting Pancreatic Cancer Early: Problems and Prospects. Semin Oncol 2007; 34: 284–294.
25. Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. JAMA 1995; 273: 1605–1609.
26. Huxley R, Ansary-Moghaddam A, Berrington DF, et al. Type-II – Diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 2005; 92: 2076–2083.
27. Pannala R, Leirness JB, Bamlet WR, et al. Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology 2008; 134: 981–987.
28. Noy A, Bilezikian P. Diabetes and pancreatic cancer: clues to early diagnosis of a. pancreatis malignancy. J Clin Endocrinol Metab 1994; 79: 1223–1231.
29. AJCC Cancer staging Handbook. The 6th edition. New York: Springer Verlag 2002.
30. Michl P, Oauls S, Gross TM. Evidence-based diagnosis and staging of pancreatic cancer. Best Pract Res Clin Gastroenterol 2006; 120: 227–251.
31. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20, 1183–1189.
32. Basso D, Valerio A, Seraglia R, et al. Putative pancreatic cancer – associated diabetogenit factor 2030 MW peptide. Pancreas 2002; 24: 8–14.
33. Benham F J, Fögh J, Harris H. Alkaline phosphatase expression in human cell lines derived from various malignancies. Int J Cancer 1981; 27: 637–644.
34. Kaaks R, Lukanova A. Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc 2001; 60: 91–106.
35. Sandhu MS, Dunger DB, Giovannucci EL. Insulin, insulin-like growth factor-I(IGF-I), IGF bindings proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst 2002; 94: 972–980.
36. Milazzo G, Giorgino F, Damante G, et al. Insulin receptor expression and function in human breast cancer cell lines. Cancer Res 1992; 52: 3924–3930.
37. Frittitta L, Vigneri R, Papa V, et al. Structural and functional studies of insulin receptors in human breast cancer. Breast Cancer Res Treat 1993; 25: 73–82.
38. Godsland IF. Insulin resistance and hyperinsulinaemia in the development and progression of cancer Clinical Science 2010; 118: 315–332.
39. Federico A, Morgillo F, Tuccillo C, et al. Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 2007; 121: 2381–2386.
Štítky
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistČlánok vyšiel v časopise
Journal of Czech Physicians
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Metamizole vs. Tramadol in Postoperative Analgesia
- Spasmolytic Effect of Metamizole
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
Najčítanejšie v tomto čísle
- Acoustic neuroma – vestibular schwannoma – personal experience of up-to-date management
- Calcitonin and his role in regulation of calcium-phosphate metabolism
- Type 2 diabetes mellitus as a subclinical inflammation
- Our experience with pancreatic cancer and its relation to diabetes mellitus